Summary: Two facts must be taken into consideration when quantifying fibronectin in biological samples: the sensitivity of the assay method and the appropiate handling of samples. A three-antibody, non-competitive ELISA was used in the present study. This procedure offers a simple, inexpensive and very sensitive technique for evaluating fibronectin: reproducible Standard curves in the ränge 5 -100 g/l, 3% variability in the assay, and a detection limit of 0.5 ng/well that allows accurate measurement of fibronectin in segmental bronchoalveolar lavage and in ascites liquid samples. Typical dilution ranged from 1/10000 for plasma to 1/100 for bronchoalveolar lavages. For long-term storage of samples two procedures are recommended. First, a rapid freezing with liquid nitrogen, storage at -20 °C and thawing once at 37 °C avoiding refreezing. Losses of immunoreactive fibronectin after 35 days storage were 15, 15 and 22% in plasma, bronchoalveolar lavages and ascites fluid, respectively. Alternatively, samples can be stored äs ammonium sulphate precipitates. This allows the easy availability of the samples when assays have to be repeated, and avoids fractionation in vials and freeze-thawing cycles. Using this storage procedure, losses are, however, slightly higher (22, 25, 25%, respectively, after 35 days).
morphology (5) , wound healing processes (6, 7) , nonimmune opsonization (8 -10) and aging of tissues (11) . Since fibronectin is involved in many important biological activities, its levels may have a potential clinical value (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) .
Two facts must be considered when quantifying fibronectin in biological fluids. First, the characteristics of a particular method; second, the correct handling of the samples to be evaluated. Concerning the first point, there have been reports on several methods used to quantify sohible fibronectin. These methods are based either on electroimmunoassays (22) , immunological precipitation (10), or turbidimetric methods, i. e. laser nephelometry (23) , radioimmunoassay (24) , or competitive ELISA (25) . Among the described methods RIA is presumably the only one with sufficient sensitivity to evaluate fibronectin in biological fluids with low fibronectin Contents. This requires the use of radiactive tracers which in the case of fibronectin, is problematic (24) . We developed (26) a sensitive three-step non-competitive ELISA to quantify animal fibronectins, which we have now adapted for evaluating small amounts of fibronectin in clinical samples.
The second factor of interest is that fibronectin is a "sticks-to-all" protein, and its handling in the clinical laboratory is critical. Significant losses of protein are frequent during Isolation and storage of samples. Both factors are important in the evaluation of fibronectin in biological samples, and the existence of contradictory data is probably directly related to those two facts.
The aim of this study was to investigate the conditions for sample collection and storage for the measurement of fibronectin by ELISA in human biological fluids.
Materials and Methods
Reagents 2,2 / -Azino-di-(3-ethyl-benzthiazoline sulphonic acid (6)) (ABTS) was from Sigma. Horseradish peroxidase (EC 1.11.1.7) was from Boehringer Mannheim. Heparin was from Rovi S. A. (Madrid, Spain). Tween-20 was from Merck, (art. N° 822184). Crystalline polystyrene microtiter plates for ßLISA were M-29 from Greiner. All other chemicals were of analytical grade.
Collection and storage of biological samples Blood was drawn from healthy fasted individuals (n = 40) by puncturing the radial vein. Three anticoagulants were used: heparin, 25 lU/ml; trisodium citrate, 11 mmol/1; or EDTA, 62 mmol/1. Plasma was separated by centrifuging the blood, 10 min at 1500g at room temperature. Serum was obtained after allowing blood to coagulate for 4 hours at room temperature and centrifuging the clot 10 min at 1-500 £.
Segmental bronchoalveolar lavage was performed in 10 individuals who were in good health and showed no Symptoms of respiratory disorders. The bronchoscope was wedged in a subsegment of a lobe and 100 ml of warm sterile saline was instilled in several portions and recovered by gentle aspiration. The samples were put on ice and filtered through two layers of surgical gauze, centrifuged to remoVe cells (20 min at 500 g) and stored äs indicated below.
Ascites liquid was obtained from patients häving ascites by intraperitoneal puncture and transferred to Containers for fufv ther storage.
Aliquots of each sample were simuitaneously kept under different conditions: a) in the cold at 4 °C with merthiolate 0.1 mg/1 or azide 0.2 g/l äs preservative; b) rapidly frozen (liquid N ? ) and stored at -20 °C; c) precipitated with ammonium sulphate at 0.50 Saturation; d) adsorbed onto micro ELISA plates and stored in the cold.
Frozen samples were thawed at 37 °C.
Preparation of fibronectin Standards and fibronectin-free albumin
Human fibronectin was prepared by affinity chromatography äs described (26) and stored in 2 mol/1 urea, l mol/1 NaCl at -20 °C. When the stock solution pf fibroneetin was examined using SDS polyacrylamide electrophoresis in the presence of mercaptoethanol, it showed a single doublet (M r 215000 and 220000), äs described (18) . Under these conditions no significant losses or degradation of fibronectin were observed after one year. Fibronectin concentration was estimated either by Lowry's method or by laser densitometry (LKB ULtroscan 2202) äs described (26) . Fibronectin-free albumin was obtained äs described (26) .
Antisera
Sheep anti human fibronectin was produced in our laboratory following conventional immunization schedules, although the commercially available Boehringer antisera was equally suitable for this assay. Rabbit anti sheep IgG's were obtained by immunizing rabbits with pure sheep IgG's. Goat anti rabbit IgG was obtained and tested äs described (26) . Rabbit IgG's anti-sheep IgG's were routinely immunoadsorbed against whole human sera prepared by insolubilization of human plasma with 10% fonnaldehyde. The IgG fraction of goat anti rabbit IgG was labelled with horseradish peroxidase according to the twostep procedure of Nakane & Kanewi (29) and assayed for its suitability for use in ELISA.
ELISA prqcedure
All assays were run äs triplicates of two independent dilütions. 1) Fibronectin Standards and tests were conveniently diluted in buffer A (sodium carbonate büffer 50 mmol/1, pH 9.6) containing 60 mg/1 of fibronectin-free albumin. Plasma düution was 1/6000 to 1/10000; 1/50 to 1/100 for segmental ..bronchoalveolar lavage and 1/1000 to 1/2000 for ascites liquid. Düuted samples (100 ) were allowed to adsorb for 30 min at 37 °C in a humid incubator.
2) The antigen excess was poured off and the plates were washed with buffer B (200 mmol/1 phosphate bufifer pH 7, 9 g/i NaCl, l ml/l Tween-20). At this stage the plates were emptied and, if not used immediately, they were stored at 4 °C without measurable loss of antigenicity. Ten days was the longest storage period tested. i 3) A volume of 100 μΐ of sheep anti-human fibronectin 1/6000 in buffer B was added to the wells and incubated at 37 °C for l hour. Each sample had its own blank well where the first antiserum was non-immune sheep IgG. After washing with bufier B, wells were again incubated for 30 min at 37 °C with 100 ul of 1/2000 rabbit anti-sheep IgG diluted in buffer B.
4) Wells were incubated with peroxidase-labelled conjugate (1/8000) for 30 min at 37 °C. Thereafter the plates were washed and 100 μΐ of 0.2 mmol/1 ABTS, 2 mmol/1 H 2 O 2 in citrate buffer 0.1 mol/1 pH 4.2 were added. The enzyme acitivty was measured after incubation at 37 °C in a micro ELISA reader (MR 600 Dynatech Lab. Inc.) at 405 nm.
Results

Collection of samples for fibronectin determination
We undertook a series of experiments to establish the conditions necessary to assure reproducible vahies of fibronectin. In blood, fibronectin was estimated either in serum or in the plasma of the same blood sample treated with different anticoagulants. The measured fibronectin content of serum was 19.66% + 5.58 (n = 40) lower than that of citrated plasma. No significant differences were found between citrated and EDTA plasma (less than 2%), but the values for heparinized plasma were significantly lower (13.21% ± 4.63; n = 40). According to our experience, plastic tubes are not appropiate sample Containers since fibronectin is known to firmly attach to plastic surfaces (26) . Losses of 5 -10% are to be expected due to this factor. The effect is even greater in samples containing low arnounts of fibronectin like segmental bronchoalveolar lavage. Fibronectin losses were negligible when Standard borosilicate glass Containers were used.
Storage of samples
A critical factor affecting the reproducibility of measurements was the storage of samples. Since for practical reasons the measurement of fibronectin was not usually performed on the day of sampling, we investigated the effects that conventional storage procedures could have on the fibronectin content of samples. Aliquots of plasma, ascites liquid and segmental bronchoalveolar lavage were stored under different conditions and their fibronectin content was measured during 35 days. At the indicated dates the samples were titrated and their relative fibronectin content calculated in relation to their initial content. As figure l a summarizes, there is a gradual loss of fibronectin in frozen and in precipitated (2.1 mol/1 ammonium sulphate) plasma samples, decreasing to 80% of the initial content by day 35. However in samples stored in the cold, their content quickly dropped below 50% of the initial values. losses of fibronectin in frozen samples after thawing was also studied. The results showed that if samples needed to be frozen, they should always be thawed in a water bath at 37 °C. When thawing at room temperature, we found a reduction of up to 20% of the initial fibronectin content. Repeated freezingthawing, even with thawing at 37 °C, greatly reduced the fibronectin content (50% after 5-cycles of freezing-thawing), and therefore should be avoided.
In a third experiment, ELISA plates were coated with the human sample the day they arrived at the laboratory, then washed, stored in the cold, but not taken through the rest of the Steps of ELISA until several days later. In relation to their initial fibronectin content, plates coated with plasma samples (n = 10) on day 0 and processed on day 10 lost only 2.7 ± 2.2% of their immunoreactive fibronectin, which was not statistically significant, whereas the same samples, stored at -20°C during this period, assayed on day 10, lost 4.1 ± 1.3%.
Titration curve: Sensitivity and precision
To measure fibronectin concentrations in samples the values of absorbance of fibronectin Standards were plotted in a semilog paper against the concentration of fibronectin, and the linear regression of absorbance against the log of concentration of fibronectin was calculated. Excellent correlations were obtained in the ränge of 0.5 -10 ng of fibronectin per well (r = 0.99). To assess the inter-assay reproducibility of the data, several calibration curves were made with fibronectin Standards. Figure 2 shows the mean ± Standard deviation of six calibration lines each made on a different day. The low deviation of values clearly shows the high reproducibility pf this assay.
Fibronectin measurement in human plasma, ascites and segmental bronchoälveolar lavage To assess the internal accuracy of this method for measuring fibronectin in human plasma, we performed the following experiment: we first prepared Standards of known concentrations of fibronectin made up by diluting the appropiate amount of fibronectin in fibronectin-free albümin. The same amounts of fibronectin were added to a previously defibronectized human plasma. These plasma Standards were processed and assayed at two different dilutions 0/4000 and Y6000) by ELISA to estimate their fibronectin content. The results obtained are repre* sented in figure 3 . There is a small underestimate of fibronectin content in plasma in relation to pure fibronectin Standards, which is slightly greater when plasma is assayed at a dilution V^OOO insteäd of a dilution Y6000. To assess intra-assay specificity and reproducibility, we measured a patieiit's plasma sample 10 times, making a new dilution each time and doing triplicate assays for each dilution. The variabik ity in the absorbance readings were quite low (0.572 ± 0.017, n = 30, 3% error). The limit of sensitivity of the technique was estijnated by determining the 
. Titration curves for fibronectin
To assess the linearity and reproducibility of the method for quantifying plasma fibronectin, increasing known amounts of fibronectin were diluted in buffer A containing 60 mg/1 of fibronectin-free albumin (o), or added to human plasma that had been previously de-fibronectinized. These were handled s routine samples, and their fibronectin content was measured by ELISA. The plasma was assayed at two different dilutions, Y4000 (a) and V6000 (o). The results represent the colour absorbance after completing the ELISA in relation to the fibronectin present in samples.
smallest ainount of fibronectin which gave an absorbance value significantly different from the blank. We used the t-test and analysed 20 negative controls and 20 positive samples. The lowest measurable concentration with this assay was 5μg/l (0.5 ng/well), p < 0.01. We also studied the effects of dysproteinaemia and hyperlipaemia on the accuracy of the method. To evaluate possible interference from variable concentr tions of total protein in individual samples, binding of fibronectin t the microplate was studied using a constant fibronectin concentration (250 μg/l) and variable amounts of fibronectin-free albumin s external protein source (0 -10 mg/1). The results showed no appreciable effects on the accuracy of fibronectin estimation over a wide r nge of external protein concentrations. The protein present in plasma samples at the dilution used in the assay 0/6000-VI0000, 1-0.6 μ^βΠ) did not interfere with the binding of fibronectin.
The possible effects of lipids on the estimates of plasma fibronectin were followed in 10 healthy human fasted volunteers. Blood was obtained and each volunteer received 150 ml of double-cream strawberry shake. After 120 min a blood sample was obtained and cholesterol, triacylglycerol and fibronectin were measured before and after the ingestion. The results presented in table l show that induced hyperlipaemia did not interfere with the fibronectin estimate in spite of the great variations in plasma lipids. Subject 9 had 1780 mg/1 triacylglycerol before the experiment and 4220 mg/1 afterwards, i. e. a 58% increase. However, fibronectin only varied by + 3%. In another case the effect was opposite; in subject 2, triacylglycerol before the experiment was 1040 mg/1, and afterwards it was 2000 mg/1, i. e. a 48% increase; fibronectin varied by -6%. In others, (subject l, triacylglycerol before: 1100 mg/1, after: 1860 mg/1; an increase of 41%) fibronectin did not change significantly (-0.01%). The mean of the variations is not significant and falls within the error of the method.
We also compared the results obtained with this procedure with literature values (tab. 2). Plasma of 40 healthy individuals, 10 healthy segmental bronchoalveolar lavages and 35 ascites of hepatic cirrhosis were studied. This ELISA, because of its sensitivity, could be used to evaluate fibronectin in segmental bronchoalveolar lavage and in ascites liquid. 9.6 ± (n = 10) 5.5-13^g/mg*) 2.7 ± 1.1
*) § of fibronectin per mg of total protein in the sample.
Discussion
Sample collection is one of the factors influencing the quality of the data. There is significantly less fibronectin in serum than in plasma, because variable amounts of fibronectin are cross-linked to the fibrin by factor XIII during coagulation (30) . We confirmed the results of Bowen et al. in the sense that citrate and EDTA gave the best results. Although plastic tubes have been recommended for plasma collection (31), our own experience and that recently pointed out by other authors (32) indicate that it should be avoided and that Standard borosilicate tubes must be used.
The storage of samples also plays an important role. Fibronectin, fonnerly known äs "cold insoluble globulin" (l, 27), precipitates in the cold together with fibrinogen and fibrinopeptides (33) . Some authors reported that it could be stored at 4 °C for short periods (32) . However, in our experience this procedure is not recommendable since very important losses occurred. We have alternatively assayed three different procedures: 1) freezing in N 2 and storage at -20 °C;
2) precipitation with 2.1 mol/1 ammonium sulphate and 3) adsorption onto micro ELISA plates and storage in the cold. fig. l a) . This disadvantage was counteracted by the simplicity of the precipitation procedure, the ease of transport and the possibility of taking several aliquots without having to thaw a vial each time.
In segmental bronchoalveolar lavage and in ascites fluid, losses of fibronectin in samples stored in the cold were so great that only the other two procedures could be considered. Losses are similar to thpse found in plasma samples ( fig. l b, c) . In both cases frozen samples retained higher amounts of immünoreactive fibronectin. However, the simplicity of the ammonium sulphate precipitation often made it the most recommendable procedure for the storage and transport of samples from the hospital to this laboratory. Among several procedures tested for long-term storage of fibronectin Standards, the best results were obtained when fibronectin was frozen (-20 °C) in 2 mol/1 urea, l mol/1 NaCl. We found no degradation or protein losses after one-year storage (data not shown).
The ELISA we used in this work is linear in the ränge of 5 -10 g/l and has a limit of detection of 5 £/1, which is comparable to l g/l reported for RIA (24, 35) , and hundreds of tirnes more sensitive than other reported immunological methods (17, 32, .36, 37) ; it thus allows the easy measurement of fibronectin in ascites and segmental bronchoalveolar lavage. Intraassay error is less than 3% when care is taken during pipetting and diluting of samples. The small differences (10 -15%) in the fibronectin content of plasma samples when values are calculated against either a pure fibronectin Standard curve or a plasma Standard curve, ( fig. 3 ) are due to the short incubation times used in the assay (30 min), which do not allow 100% adsorptiön of fibronectin (26) and are minimized when adsorption of samples is £roloriged for several hours.
Changes in the protein content of plasma have no effect on the accuracy of estimates, since samples are diluted in fibronectin-free albumin at a final concentration of 6 μg/well and the plasma sample only contributes 0.6 to l μ §/ννβ11. In plasma with a lower protein concentration this contribution may be lower and, therefore, according to previous results (26) , the absorption of fibronectin to plastic will be the same. The presence of triacylglycerol and cholesterol (chylomicrons) did not appreciably interfere with the fibronectin estimate. The experiment summarized in table l analysed 10 cases and, although the lipid Variation in each individual before and after the ingestion of cream varied greatly, the fibronectin content did not change during the experiment.
The values we obtained in plasma are in agreement with those previously reported and assayed by other methods, (tab. 2). However our data for fibronectin in ascites and segmental bronchoalveolar lavage are slightly higher but with lower S.D., a fact that is probably related to the greater sensitivity of the EL-ISA.
